Blood Chemistry Study in Mild ARDS
Part of Lungs & breathing clinical trials.
This study uses a special blood test (called NMR metabolomics) to understand how your body's chemistry changes in the early stages of mild ARDS. It may help find better ways to treat this serious lung condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have been diagnosed with mild ARDS (acute respiratory distress syndrome) that started in the last 3 days.
- Doctors expect you to live more than 3 days.
- Your family agrees to your participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how thick your blood is to see if it plays a role in ARDS, a severe lung injury that makes breathing very difficult. It may help doctors understand the condition better and improve future treatments.
This study is for patients in the ICU with ARDS (a severe lung condition). It looks at biomarkers (special substances in your blood) to help understand different types of ARDS. You do not receive any treatment, but you help researchers learn more about the disease.
This study looks at blood and sputum samples from people with ARDS (a serious lung condition) to find clues that might predict how well they will recover. The goal is to improve care and outcomes for future patients.
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
This study collects health information from ICU patients with or at high risk for ARDS to better understand the condition and develop a tool to help doctors make decisions. It may not directly help you, but it could improve care for future patients.
This study looks at the real-world features, treatments, and outcomes of people with acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe. If you are on certain types of breathing support and meet the oxygen and lung scan criteria, your participation may help improve care for others with this condition.
Hear when a new ARDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.